Real Life Experience of the Use of CDK 4/6 Inhibitors in the First Line Treatment of Metastatic ER+ Her2– Breast Cancer: Focus in Neutropenia and Dose Reduction C. Blake,S. Cleator,A. BrownClinical Oncology（2020）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
